3 independently sourced, verified news trends involving Merck.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Jul 16, 2026 through Aug 20, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
Merck raised its sales forecast while cutting profit guidance following recent acquisition charges.
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.